Who makes GIP[3-30]NH2?

GIP[3-30]NH2 is developed by Frederikke Koefoed-Hansen.

Last reviewed 2026-04-19 · How we verify

GIP[3-30]NH2

Frederikke Koefoed-Hansen · Phase 1 active Biologic

At a glance

Generic name	GIP[3-30]NH2
Sponsor	Frederikke Koefoed-Hansen
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GIP[3-30]NH2 CI brief — competitive landscape report
GIP[3-30]NH2 updates RSS · CI watch RSS
Frederikke Koefoed-Hansen portfolio CI